Like this article? PLEASE +1 it! Evan Signature
Evan Carmichael Top Header about About Home Profiles articles Tools forums inspirational quotes About facebook Twitter YouTube Blog
Share for a Cause











Infant Death From Overdose of Blood Thinner Heparin Tragically Was Not the First

Guest post by: Terry Cochran

Article Overview: Heparin is commonly administered after surgery or during kidney dialysis to keep blood in IV lines from clotting. But an incorrect dosage can lead to immediate consequences because a patient can quickly start bleeding internally. Some hospitals stopped using Heparin on infants in 2008, substituting a saline solution as a lower-risk alternative.

Free Download - Sailors, Maritime Workers Protected By Special Laws For On-the-Job Injuries By Terry Cochran
Name: Email:

Infant Death From Overdose of Blood Thinner Heparin Tragically Was Not the First

It happened again - an infant tragically died in a Nebraska hospital because of an overdose of the blood thinner heparin.

The tragic death of 23-month-old Almariah Duque on April 2, 2010 is one in a series of infant deaths or near-death episodes caused by hospital personnel administering the wrong dose of heparin, among them being:

• 2008 Corpus Christi, Texas, 14 infants suffer from Heparin overdoses of which two babies died

• 2006 Indianapolis, Indiana, Heparin overdoses administered to six premature babies of which three infants died.

• 2007 Los Angeles the twins of actor Dennis Quaid were administered quantities of Heparin that were 1,000 times higher than the dose authorized by doctors. Fortunately the twins survived.

Almariah Duque was taken to the Nebraska Medical Center in Omaha for a liver, kidney and bowel transplant in December 2009. After suffering from an infection in February 2010 Almariah returned to the hospital for treatment and died from what the hospital admitted was likely caused by an overdose of heparin.

Heparin is commonly administered after surgery or, in Almariah's case, during kidney dialysis to keep blood in IV lines from clotting. But an incorrect dosage can lead to immediate consequences because a patient can quickly start bleeding internally. Some hospitals stopped using Heparin on infants in 2008, substituting a saline solution as a lower-risk alternative.

The accidental overdose of Almariah Duque is one of about 1.5 million medical mistakes made in the U.S. every year.

And, according to a United States Pharmacopeia study released in March 2007, children are almost three times as likely as adults to be harmed by medical mistakes.

The Quaid twins, Thomas Boone and Zoe Grace, were given 1,000 times the normal concentration of Heparin, a blood thinner used to prevent clots, at Cedars-Sinai Medical Center in Los Angeles, on November 19, 2007. The twins were born November 8, 2007.

The Quaids filed a lawsuit on December 4, 2007, in Cook County, Illinois, Circuit Court against the makers of Heparin claiming Baxter Healthcare Corp. was negligent in packaging different doses of the drug in similar vials with blue backgrounds. In December 2008 the Quaids settled the lawsuit for $750,000. The hospital also was fined $25,000 by the California Department of Public Health for the overdose.

Sadly, the massive overdose to the Quaid twins is but one of thousands of mistakes made by doctors and medical staff every day. If the life of the Quaid twins can be put in peril by a massive overdose at such a renowned hospital, we must wonder how safe are the more anonymous babies lying in hospital nurseries less reputable than Cedars Sinai.

"My experience in private practice includes several instances of parents coming to me because their babies had been harmed while under hospital care," says Lynn Foley, a senior partner in my law firm who is an RN specializing in medical malpractice. "To protect the child's economic future, and to provide lifetime care, I have advised parents to bring legal action. There also are times when the purpose of a lawsuit is to prevent future harm happening to other babies and that was the motive of the Quaid's lawsuit against the manufacturers of Heparin."

The results of some of the lawsuits in which Lynn Foley was lead attorney include a $15.8 million verdict, the largest in Michigan for 2006, for a medical error to a baby causing Cerebral Palsy, recovery of $1.2 million on behalf of a baby born with Spina Bifida, and recovery of $900,000 for the parents of a baby born with Downs Syndrome.

The Institute for Safe Medication Practices lists anti-coagulants, including Heparin, as high-alert medications, because they have "a heightened risk of causing significant patient harm" when used in error." The Quaid twins survived the massive overdose and are now doing well, according to a family spokesman, but too many similar victims are not as fortunate.

In 2006 three babies died at an Indianapolis hospital after a pharmacy technician stocked a medicine cabinet with vials containing Heparin with a concentration 1,000 times stronger than what was normally kept there. Nurses didn't check the label and administered the wrong dosage. The Quaid lawsuit filed Dec. 4 says Baxter Healthcare should have recalled the large-dosage vials after the Indianapolis deaths.

Baxter Healthcare Corp. had been aware of the potential overdose problem with Heparin long before the overdose to the Quaid twins was administered. On February 6, 2007, Baxter sent a Safety Alert to its healthcare provider network about a potential life threatening medication error of its two Heparin products - the Heparin Sodium injection with 10,000 units per milligram and the HEP-LOCK U/P injection with 10 units per milligram.

In that alert Baxter admitted it was "aware of fatal medication errors that have occurred when two Heparin products with shades of blue labeling were mistaken for each other."

The alert made mention of three infant deaths that had occurred because the higher dose was "inadvertently administered."

Baxter issued a reminder to healthcare professionals which could have avoided the totally unnecessary overdose to the Quaid twins and which also contains some sound general procedures to follow before administering other medications. The reminder noted:

* Never rely on color as a sole indicator to differentiate product identity.

* Always carefully read the product label to verify that the correct product name and strength have been selected.

* Always carefully review both the drug name and dose on the label before dispensing and administering these products.

* Double-check your inventory as soon as possible, to ensure that there is no mix-up of the products.

* Notify all staff of the potential for errors in dispensing and administering these products. It is advised that you provide color photographs ... to staff to assist in their understanding of the product similarities.

Given the existence of this clearly worded Safety Alert from Baxter, the Quaids attorney (Susan E. Loggans & Associates, P.C.) rightly asserted that Baxter is negligent because it failed to recall and failed to repackage products it knew were life-threatening.

Baxter's failure to recall or repackage may seem incredible to many but, unfortunately, this behavior is repeated far too often by pharmaceuticals whose hunger for profits prevents them from spending money to recall or repackage products known to be potentially life-threatening. For that and other reasons, healthcare consumers will continue to need the services of medical malpractice legal specialists who will advocate for them and protect them from unthinking and careless hospitals and healthcare professionals.

Most people do not realize that more than 700,000 Americans die each year because of medical mistakes. Victims need an attorney to uncover the truth because most medical malpractice mistakes are covered up by doctors and hospitals. As an attorney and Registered Nurse my knowledge and insight of the operating room as well as the courtroom has proved beneficial in bringing well-deserved justice to victims of tragic medical mistakes.

Related Articles
  WHAT YOU NEED TO KNOW ABOUT BUYING A FRANCHISE
  High Blood Pressure (Hypertension) and its Treatment
  Remedies for High Blood Pressure
  Life Trumps Death
  The Risk of Heart Disease in Professional Women
  Suicidal Ideations
  Aspirin
  STRESS-- A NATURAL RESPONSE?
  Innovative Home-Based Business - Teaching Babies Sign Language
  Lesson #4: Tread Carefully Into New Waters
  Life and Death
  Stages of Corporate Life
  Sales Query Answer
  Arguments for Free Trade
  Be A Model For Your Kids
  The Great New World at 60 Plus (60+)
  Death, Public Speaking, and Seniors' Homes
  A Search for Atoning Blood
  EXTEND YOUR BOUNDARIES
  Health Habits: Protect Against Cancer

Home > Legal > Terry Cochran > Infant Death From Overdose of Blood Thinner Heparin Tragically Was Not the First >
Article Tags: blood thinner, Cochran Foley, Dennis Quaid, herapin, medical malpractice, overdose, Quaid, Terry Cochran
Referred by: http://www.westwindcos.com

About the Author: Terry Cochran
RSS for Terry's articles - Visit Terry's website

Terry Cochran is a senior partner in Cochran, Foley & Associates, P.C., a Michigan law firm specializing in personal liability, medical malpractice, and auto and truck accidents (http://www.youtube.com/watch?v=jpFU0CZv4pM). Cochran does not represent insurance companies or corporations but instead bases his practice upon representing individuals and families. www.cochranfoleypc.com

Click here to visit Terry's website
Dashed Line

More from Terry Cochran
Whats Wrong With Michigan Workers Compensation Worker Who Defended Customer Left with $300000 Medical Bill By McDonalds
Sailors Maritime Workers Protected By Special Laws For OntheJob Injuries
Entrepreneurs Caution Customers that Boaters Who Ignore Common Sense Drown in Their Own Foolishness
Construction Accidents Michigans Most Dangerous Work Injured Workers Often Denied Claim for Recovery of Damages
Businesses Know That Benefits For the Disabled Usually Denied When First Requested


Related Forum Posts
Re: Reached 2 year mark and not sure what to do next Re: Reached 2 year mark and not sure what to do next - Hi Franklin007, I know your post was old and surprised it wasn't answered but hey i will have a go at it. Blood, sweat and tears should be valued when it comes to the value of a business, however, considering they say a business move mark is 2 years, I would say you are doing pretty well for no startup capital, you and your partner should be proud of yourselves, pat on the back for you both (as a business owner who sleeps 4 hours a night and works 7 days a week, i know your pain). Valuing a business can be done many ways, the best suggestion I could give would be to talk to a business broker followed by an accountant, no disrespect to business brokers, however, I have had many discussions with several of them and no, i won't, i just suggest talk to a couple of business brokers for their advice then see your accountant etc. With your business you created, their is more to it than just "whats in the bank" you have a customer base of advertisers, you have a subscriber base or could potentially get one, you have software/hardware, printers or whatever equipment you may have, all of this together forms your business, therefore it all shoudl be considered. I hope this helps, if its too late, let me know how you went. Steven Hayes


Share this article with your friends. Fund someone's dream.

Leave a comment below or share on the left and you'll help support entrepreneurs in Africa through our partnership with Kiva. Over $50,000 raised and counting - Please keep sharing! Learn more.



Featured Article

Bottom Footer



Newsletter

Get advice & tips from famous business
owners, new articles by entrepreneur
experts, my latest website updates, &
special sneak peaks at what's to come!
Name:
Email:
Popular Articles

Selling with Humor (and a Sorry Butt)

Multilevel Marketing: 4 Tips To MLM Success

10 Steps to a Great Support Team

Suggestions

Email us your ideas on how to make our
website more valuable! Thank you Sharon
from Toronto Salsa Lessons / Classes for
your suggestions to make the newsletter
look like the website and profile younger
entrepreneurs like Jennifer Lopez.